Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Костянтин Васильович Курищук, Константин Васильевич Курищук, Наталія Юріївна Діденко, Наталия Юрьевна Диденко, Валентина Миколаївна Винокурова, Любов Володимирівна Заря, Віктор Петрович Георгієвський, Виктор Петрович Георгиевский, Лариса Миколаївна Андрюкова, Лариса Николаевна Андрюкова, Олена Анатоліївна КрасічковаfiledCriticalКостянтин Васильович Курищук
Priority to UA2000127672ApriorityCriticalpatent/UA39712C2/en
Publication of UA39712ApublicationCriticalpatent/UA39712A/en
Publication of UA39712C2publicationCriticalpatent/UA39712C2/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Medicinal Preparation
(AREA)
Abstract
The invention relates to the pharmacology, in particular to the dosage forms of interferon useful for ophthalmology. The aim of the invention consists in providing for the biological activity of interferon in pharmaceutical composition and the eye-drops containing such composition allowing for increasing shelf-life of the product up to three years. The composition contains 1∙105-6∙106 IU of interferon per 1 ml of ethylene glycol free aqueous solution. In addition, the composition contains 0.04-0.055 g of dextrane and phosphate buffer, pH 4.0-8.0. The composition is produced as freeze-dried powder. According to the invention, the eye-drops are reconstituted at 1:1 ratio of freeze-dried powder and the solvent.
UA2000127672A2000-12-292000-12-29Pharmaceutical composition and eye-drops containing interferon
UA39712C2
(en)
Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds